• 열처리공학회지
• /
• 제14권2호
• /
• pp.124-131
• /
• 2001

• 열처리공학회지
• /
• 제16권2호
• /
• pp.97-103
• /
• 2003

• 대한약침학회지
• /
• 제17권1호
• /
• pp.20-26
• /
• 2014

Objectives: The study aimed to determine changes in laboratory data for cancer patients receiving Korean medicine (KM) care, with a focus on patients' functional status, cancer-coagulation factors and cancer immunity. Methods: We conducted an observational study of various cancer patients in all stages admitted to the East-West Cancer Center (EWCC), Dunsan Korean Hospital of Daejeon University, from Mar. 2011 to Aug. 2011. All patients were under the center's multi-modality Korean-medicine-based inpatient cancer care program. The hospitalization stay at EWCC ranged from 9 to 34 days. A total of 80 patients were followed in their routine hematologic laboratory screenings performed before and after hospitalization. Patients were divided into three groups depending on the status of their treatment: prevention of recurrence and metastasis group, KM treatment only group, and combination of conventional and KM treatment group. The lab reports included natural killer cell count (CD16 + CD56), fibrinogen, white blood cell (WBC), lymphocytes, monocytes, neutrophil, red blood cell (RBC), hemoglobin, platelet, Erythrocyte Sedimentation Rate (ESR), and Eastern Cooperative Oncology Group (ECOG) performance status. Results: With a Focus on patients' functional status, cancer-coagulation factors and cancer immunity, emphasis was placed on the NK cell count, fibrinogen count, and ECOG scores. Data generally revealed decreased fibrinogen count, fluctuating NK cell count and decreased ECOG, meaning improved performance status in all groups. The KM treatment only group showed the largest decrease in mean fibrinogen count and the largest increase in mean NK cell count. However, the group's ECOG score showed the smallest decrease, which may be due to the concentration of late-cancer-stage patients in that particular group. Conclusions: Multi-modality KM inpatient care may have positive effect on lowering the cancer coagulation factor fibrinogen, but its correlation with the change in the NK cell count is not clear.

• 열처리공학회지
• /
• 제16권3호
• /
• pp.165-171
• /
• 2003

• 열처리공학회지
• /
• 제3권3호
• /
• pp.52-57
• /
• 1990

• 열처리공학회지
• /
• 제16권4호
• /
• pp.232-238
• /
• 2003

• 대한치과보철학회지
• /
• 제47권3호
• /
• pp.286-294
• /
• 2009

연구목적: 우리 사회가 선진화 됨에 따라 장애인과 장애인의 사회복지에 대한 관심이 점차 증가되고 있으며 장애인의 의료환경에 대한 연구도 차츰 늘어가고 있다. 하지만 그 동안 증가하는 장애인 치과 진료의 수요 및 관심에 비해 장애인 보철 진료에 대한 연구가 전무한 실정이었다. 본 연구는 치과의사가 바라본 현행 대한민국의 장애인 보철 진료 실태와 인식에 관해 조사하였다. 연구 재료 및 방법: 전국의 장애인 진료를 하는 치과 병의원 및 복지기관, 보건소의 치과의사 87명을 대상으로 총 11문항으로 구성된 설문지를 발송하여 68부의 유효한 설문지를 회수하여 통계 분석하였다. 결과 및 결론: 1. 조사 대상 치과의사 중 45.6%가 일반인과 마찬가지로 장애인에게도 심미보철 진료가 필요하다는 데에 긍정적으로 답변하여 시대의 흐름에 따라 과거 기능회복 위주였던 장애인 치과치료에서 점차 심미적인 고려가 필요함을 보여주었다. 2. 보철 진료의 이상적인 진료비 지불방식에 대한 조사결과 정부로부터의 재정지원이 필요하다는 의견이 79.4%를 차지하였고, 그 중 66.7%의 응답자가 그 규모를 일반보철 수가의 최소 50%이상을 정부가 지원하는 것이 적절하다고 응답했다. 현재 우리나라 장애인 보철 진료 실태에 관해 97.1%의 응답자들이 열악하다고 인식하고 있었다. 이러한 문제의 원인으로는 장애인의 협조도 부족 문제를 제외하면 재정적인 부분이 가장 컸다. 따라서 향후 정부의 장애인 보철 진료에 대한 현실적인 지원 방안이 마련되어야 할 것으로 생각된다.

• 대한물리치료과학회지
• /
• 제7권2호
• /
• pp.483-494
• /
• 2000

The purpose of this study was to contribute to quality improvement with physical therapy service and determining the factors affecting patients' satisfaction. The study subjects were ambulatory and admitted patients treated with physical therapy at B general hospital located in Taejon from July 15, 2000 to July 21. Authors developed structured questionnaire, and distributed it to each physical therapist of B general hospital. Total number of distributed questionnaire was 164, and 157 questionnaire were collected and analysed finally. Demand of physical therapy for quality improvement(QI) related to treatment time(r =0.746, P<01), treatment method(r =.664, P<.01). treatment effect(r=0.648, P<.01), equipments(r=0.620, P<.01), cleaning status(r =0.619, P<.01). Willingness to revisit and recommendation of this physical therapy room related to treatment method(r=0.489, P<.01), treatment time(r=0.469, P<.01), cleaning status(r=0.432, P<.01).

• 대한조현병학회지
• /
• 제24권1호
• /
• pp.1-7
• /
• 2021

Clozapine is the first and most effective atypical antipsychotic drug for treatment-resistant schizophrenia (TRS). After withdrawal of clozapine due to concerns of agranulocytosis, clozapine was reintroduced with a comprehensive safety monitoring system, the clozapine patient monitoring system (CPMS). The reintroduction was a response to the pressure from psychiatrists and patients with TRS and their families. Clozapine is still the best single agent for the treatment of TRS. However, approximately 30% of patients with TRS still show psychotic symptoms. In patients with clozapine-resistant schizophrenia (CRS), augmentation of other antipsychotic agents could be considered after a thorough evaluation of proper clozapine treatment. In this review, the status of clozapine in patients with TRS and CRS will be discussed.

• Asian Pacific Journal of Cancer Prevention
• /
• 제13권12호
• /
• pp.6491-6496
• /
• 2012

Background: The influence of parental socio-economic status on childhood cancer treatment outcome in low-income countries has not been sufficiently investigated. Our study examined this influence and explored parental experiences during cancer treatment of their children in an Indonesian academic hospital. Materials and Methods: Medical charts of 145 children diagnosed with cancer between 1999 and 2009 were reviewed retrospectively. From October 2011 until January 2012, 40 caretakers were interviewed using semi-structured questionnaires. Results: Of all patients, 48% abandoned treatment, 34% experienced death, 9% had progressive/relapsed disease, and 9% overall event-free survival. Prosperous patients had better treatment outcome than poor patients (P<0.0001). Odds-ratio for treatment abandonment was 3.3 (95%CI: 1.4-8.1, p=0.006) for poor versus prosperous patients. Parents often believed that their child's health was beyond doctor control and determined by luck, fate or God (55%). Causes of cancer were thought to be destiny (35%) or God's punishment (23%). Alternative treatment could (18%) or might (50%) cure cancer. Most parents (95%) would like more information about cancer and treatment. More contact with doctors was desired (98%). Income decreased during treatment (55%). Parents lost employment (48% fathers, 10% mothers), most of whom stated this loss was caused by their child's cancer (84% fathers, 100% mothers). Loss of income led to financial difficulties (63%) and debts (55%). Conclusions: Treatment abandonment was most important reason for treatment failure. Treatment outcome was determined by parental socio-economic status. Childhood cancer survival could improve if financial constraints and provision of information and guidance are better addressed.